Navigation Links
AmbiCom Forms Joint Alliance With E-Care Technology Corporation
Date:6/13/2011

MILPITAS, Calif., June 13, 2011 /PRNewswire/ -- AmbiCom Holdings, Inc. (OTCQB: ABHI), a leader in the development of wireless products for medical equipment suppliers, today announced that it has signed an agreement to form a joint alliance between its AmbiCom Technology, Inc. ("ATI") subsidiary and E-Care Technology Corporation, ("ECT") Taiwan. The agreement became effective May 1, 2011 and runs for a period of three years.

ECT is a leading manufacturer of infrared ear thermometers in Taiwan and also develops other medical devices such as intra-oral camera (dental camera). Under this joint alliance, ECT will develop, test and manufacture infrared ear thermometers and other medical devices as ATI private-labeled products under the brand name "E-Care USA, Inc." This agreement effectively gives AmbiCom new access to the $304 million market for wirelessly connected home health care devices.

"The joint alliance enables us to aggressively enter the home health care market with a differentiated, state-of-the-art suite of products utilizing our wireless technology platform," commented John Hwang, CEO and Chairman of AmbiCom. "As discussions with ECT progressed, it became clear that a joint alliance was more favorable to our shareholders than the previously contemplated merger, as this agreement provides AmbiCom with access to state-of-the-art medical devices and robust engineering to integrate our wireless communications components. Together, we expect to develop and introduce a superior product to US customers by the end of this year. This is another example of our solid relationships within the medical device industry, and we expect the joint alliance will allow both of our companies to leverage their core competencies cost effectively, in order to deliver this product and potential follow-on products in a timely manner."

About AmbiCom

AmbiCom is headquartered in Milpitas, California, and is a leading designer and developer of wireless products focusing on the wireless medical industry. The Company's wireless modules and devices are based on the Company's innovative application software for both Wi-Fi and Bluetooth technologies. AmbiCom is committed to wireless design and development of software and hardware, and to bringing new and innovative products to the wireless medical markets and other sectors. The Company plans to grow organically, and to augment that growth by selectively acquiring complementary products and technologies via acquisition opportunities deemed to be of strategic value.

Forward-Looking Statements

This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements including, but not limited to, our ability to maintain our website and associated computer systems, our ability generate sufficient market acceptance for our shipping products and services, our inability to generate sufficient operating cash flow, and general economic conditions. Readers are urged to carefully review and consider the various disclosures made by us in the our reports filed with the Securities and Exchange Commission, including those risks set forth in the Company's Current Report on Form 8-K filed on November 13, 2007, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward- looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contact:
Dave Fore, Client Manager and Senior Research Analyst, Hayden IR: (206) 395-2711 or dave@haydenir.com


'/>"/>
SOURCE AmbiCom Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AmbiCom Retains Hayden IR to Develop Strategic Investor Relations Program
2. Major Medical Diagnostics Manufacturer Signs Agreement to Use AmbiCom Wireless Solution in Its Urinalysis Product Line
3. AmbiCom Renews and Expands Line of Credit With East West Bank
4. Allegheny General Hospital Performs First Liver Transplant
5. Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study
6. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
7. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
8. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
9. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
10. First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
11. InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, Inc. ... genome editing, announced that the U.S. Food and ... New Drug (IND) application for SB-318, a single ... for Mucopolysaccharidosis Type I (MPS I). The SB-318 ... to initiate a Phase 1/2 clinical study (SB-318-1502) ...
(Date:2/8/2016)... , February 8, 2016 ... new report published by Allied Market Research titled, ... Opportunities and Forecasts, 2014-2020", estimates the world synthetic ... Nucleotide synthesis and sequencing technology segment would continue ... and software tools segment, collectively, held around half ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, PLC, ... eine Infografik mit dem Titel „Epilepsy Around ... mit der der Krankheit gegenüber ein größeres ... ermutigen soll, Medikamentenresistenz bei Epilepsie auf dem ... Diskussion zu machen. Mithilfe der neuen Infografik ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... 08, 2016 , ... Local insurance agency Dennis Fuller & ... has initiated a fundraiser for a two year old little girl named Bella, ... To support this beautiful child who is facing life’s journey without her loving ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... networking and relationship-marketing firm, announced today that nominations will be accepted February ... (ISE®) West Awards. , Awards include the Information Security Executive® of ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... frequently. While a significant number of women and men with eating disorders report ... itself, that best predicts the development of an eating disorder. , At ...
(Date:2/8/2016)... ... 2016 , ... Discover the Rocky Mountain region’s longest running and impressive garden ... Attendees also get to see the most incredible gardens and home improvement experts that ... the Colorado Convention Center - 700 14th St. Denver CO, is an exciting event ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... share this important news! AHCC and the Home Health and Hospice ICD-10 Transition ... designee for official ICD coding guidance and clarifications, to address concerns over the ...
Breaking Medicine News(10 mins):